Hendrik Strydom - 15 Nov 2022 Form 4 Insider Report for ASP Isotopes Inc. (ASPI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Nov 2022, 11:44:48 UTC
Prior SEC filing
14 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Hendrick Strydom, Ph.D.

Key filing fact

Hendrik Strydom filed Form 4 for ASP Isotopes Inc. (ASPI) on 16 Nov 2022.

Key facts

  • This page summarizes Hendrik Strydom's Form 4 filing for ASP Isotopes Inc. (ASPI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Nov 2022, 11:44.

Change

  • Previous filing in this sequence was filed on 14 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPI transaction

Common Stock

Award

Transaction value
$0
Shares
+200,000
Change %
+5.6%
Price
$0.000000
Shares after
3,797,423
Date
15 Nov 2022
Ownership
See Footnote
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The special one-time award of 200,000 restricted shares were contingent upon the completion of our IPO. Dr. Strydom will receive 100,000 restricted shares of our common stock on November 15, 2023 and 100,000 restricted shares of our common stock on November 15, 2024.

Footnote F2

Dr. Strydom beneficially owns 3,797,423 shares indirectly through Tianne Holdings (Pty) Ltd.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .